Poly Medicure
Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
DitchCarbon Score
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Poly Medicure's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Poly Medicure's reported carbon emissions
In 2024, Poly Medicure reported total carbon emissions of approximately 2,319,850 kg CO2e for Scope 1 and about 33,962,280 kg CO2e for Scope 2, totalling around 36,282,130 kg CO2e globally. This data reflects a consistent reporting approach, as similar figures were recorded in 2023, with Scope 1 emissions at 2,319,850 kg CO2e and Scope 2 emissions at 33,962,280 kg CO2e, indicating stable operational emissions over the year. Poly Medicure has not disclosed any Scope 3 emissions data, which typically encompasses indirect emissions from the supply chain and product use. Furthermore, there are currently no specific reduction targets or climate pledges outlined in their sustainability initiatives, suggesting a potential area for future commitment. The emissions data is not cascaded from any parent organisation, indicating that Poly Medicure Limited independently reports its emissions. The company operates with a focus on transparency, as evidenced by its detailed disclosures in sustainability reports. Overall, while Poly Medicure has established a baseline for its carbon emissions, the absence of reduction targets highlights an opportunity for the company to enhance its climate commitments in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,114,940 | 0,000,000 | 0,000,000 |
| Scope 2 | 30,230,620 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
